Clinical Trial Update: A Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the Treatment of Chronic Pain [Phase 2]

View source ↗

Summary

Phase 2 safety and effectiveness study of MDT2004 intraspinal gabapentin for chronic pain was terminated, with study results posted in June 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intractable Pain

Drugs mentioned

• MDT2004 intraspinal gabapentin (gabapentin)

Snippet

Sponsor: MedtronicNeuro | Conditions: Chronic Intractable Pain | Phase 2 | Status: TERMINATED | Results posted: 2011-06-08